Relating to ibogaine; prescribing an effective date.
About This Bill
Latest Action · Mar 7, 2026
In committee upon adjournment.
Session
2026R1
Introduced
Feb 2, 2026
Primary Sponsor
Alek Skarlatos· primary
Summary
Highlight any text to annotate
Allows an attending physician to provide ibogaine to a patient for the patient's consumption to treat certain disorders. Defines "attending physician" and "ibogaine." Exempts ibogaine, when obtained, provided and consumed as specified, from the definition of "controlled substance." Takes effect on the 91st day following adjournment sine die.